Dextromethorphan for Tardive Dyskinesia

Journal Title: International Neuropsychiatric Disease Journal - Year 2014, Vol 2, Issue 3

Abstract

Aims: To report three cases of successful treatment of tardive dyskinesia (TD) with dextromethorphan. Study Design: Retrospective chart review. Place and Duration of Study: Private outpatient practice in Syracuse, NY. Methodology: A retrospective chart review of patients with TD who were treated with dextromethorphan between 2003 and 2013 was conducted. Results: Three consecutive patients experienced marked improvement of TD with dextromethorphan. Conclusion: Dextromethorphan may be a useful drug for treating TD. Further prospective studies are needed.

Authors and Affiliations

Thomas L. Schwartz, Jungjin Kim, James Donovan

Keywords

Related Articles

Potential of Stimulants to Augment Rehabilitation in the Acute Stroke Setting: Preliminary Support

Aims: The objective of these case studies is to explore the possibility of using neurostimulants during the acute stage of stroke to facilitate effective rehabilitation of patients with severe strokes. Presentation of Ca...

Influence of Psychotropic Drugs upon Neuropsychological Test Performance

Commonly used psychotropic medications are widely presumed to have deleterious effects on neuropsychological test performance. However, given the special difficulties of neuropsychological assessment with psychiatric pop...

Theory of Mind Development is Impaired in 4-Year-Old Children with Prenatal Exposure to Maternal Tobacco Smoking

Aims: Theory of Mind (ToM) is an important component of social cognition. Deficits in ToM are found in various neurodevelopmental disorders and social and environmental factors have been found to influence ToM developmen...

Novel and Investigational Drugs in Depression

Major depressive disorder is a serious medical illness associated with significant burden. Our current treatments for depression are limited, which has motivated researchers to explore novel targets. This article will hi...

An Interesting Dream as a Provoking Factor for Relapse in a Patient with Multiple Sclerosis: A Case Report

Aim: To present a patient suffering from multiple sclerosis (MS) with the noticeable conformity to dream elements with what had occurred in subsequent days (i.e. the relapse of MS). Presentation of Case: The patient is a...

Download PDF file
  • EP ID EP241494
  • DOI 10.9734/INDJ/2014/7970
  • Views 119
  • Downloads 0

How To Cite

Thomas L. Schwartz, Jungjin Kim, James Donovan (2014). Dextromethorphan for Tardive Dyskinesia. International Neuropsychiatric Disease Journal, 2(3), 136-140. https://europub.co.uk/articles/-A-241494